The Seagen and Genmab antibody drug conjugate (ADC), named Tivdak, is approved to treat cases of cervical cancer that have returned or spread following treatment with chemotherapy. Tivdak is Seagen’s third ADC; for Genmab, the drug will become its first commercialized product.
It is unclear why the American Cancer Society would potentially impact the lives of countless women with recommendations that contradict decades of real progress.
The company said the agency told it that it may consider data from an amended version of the trial of LN-145 for approval. An analyst wrote that approval could happen in the first half of 2021, based on Iovance's guidance for regulatory submission.
The Series A financing round of $2.25 million will be used to move forward with the development of its point-of-care diagnostic tools for the accurate detection of epithelium cancers, with a primary focus on cervical cancer.
Genentech, whose drug Avastin is approved to treat advanced cervical cancer, has launched a contest offering $50K to startups with innovative approaches to address the disease.
San Diego startup Hera Therapeutics is developing a topical antiviral drug that attacks human papillomavirus – and early studies are showing it can successfully combat three strains, including two that cause 70 percent of all cervical cancer. The drug candidate, HTI-1968, blocked the replication of HPV-16, HPV-18 and HPV-11 cells, according to the NIAID-sponsored study. The work […]
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
You never want to be the last speaker at the end of a long conference day. Many people in the 4:30 slot even mention this strategic disadvantage, “I know I am standing between you and happy hour, so I’ll make it quick.” The best end-of-the-day speaker I have ever heard was Dr. Victor Montori at […]
Cervical cancer is the easiest female cancer to prevent, because there are highly effective vaccines available, and precancerous cells can be detected by Pap tests and treated before they turn into cancer. Yet, in some areas of the world with lower incomes, cervical cancer incidence rates are still high, partially because of limited access to […]
